Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Oracle Corporation’s (ORCL) U.S. Securities and Exchange Commission filings, giving investors a primary source of information on the company’s governance, capital structure, and material events. Oracle’s common stock, par value $0.01 per share, is registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ORCL, as disclosed in multiple Forms 8‑K.
Among Oracle’s key filings are current reports on Form 8‑K, which document events such as quarterly financial results, cash dividend declarations, leadership and board changes, and significant financing transactions. Recent 8‑K filings describe press releases announcing fiscal quarter results, the declaration of cash dividends on Oracle’s common stock, the promotion of executives to Chief Executive Officer roles and Principal Financial Officer, the appointment and retirement of directors, and the issuance of senior notes under an existing shelf registration statement.
Oracle’s definitive proxy statement on Schedule 14A (DEF 14A) outlines matters for its annual meeting of stockholders, including the election of directors, an advisory vote on executive compensation, and ratification of its independent registered public accounting firm. The proxy statement also discusses board structure, committees, corporate governance guidelines, stock ownership policies, and executive compensation programs.
Investors may also find Form 25 filings relevant for specific Oracle debt securities. Oracle has filed a Form 25‑NSE relating to the removal from listing of its 3.125% Notes due 2025 from the New York Stock Exchange. This filing concerns a class of notes and is separate from the listing of Oracle’s common stock.
On Stock Titan, Oracle’s SEC filings are organized chronologically and can be paired with AI‑powered summaries that explain the purpose and implications of each document. This helps readers quickly understand items such as 8‑K event descriptions, proxy proposals, and capital markets transactions, while still allowing direct access to the full text of Oracle’s submissions to the SEC.
Naomi O. Seligman, a director of Oracle Corporation (ORCL), reported transactions in Oracle common stock on 09/26/2025. The filing shows a sale of 2,222 shares at $288.91 (transaction code S), followed the same day by a gift of 1,406 shares (transaction code G) with no cash consideration. After those transactions the reporting person is shown as directly owning 29,225 shares following the sale and 27,819 shares following the gift. The filing discloses 6,000 shares held indirectly by spouse and 14,414 shares held indirectly by a trust. An administrative correction notes 10 shares were previously overreported. The Form 4 is signed by attorney-in-fact Aimee Weast on behalf of Ms. Seligman.
Michael D. Sicilia, listed as Chief Executive Officer, reported the acquisition of a large stock option award in Oracle Corporation (ORCL). The Form 4 shows a derivative transaction dated 09/24/2025 in which 1,037,412 stock options were acquired with an exercise (conversion) price of $308.46. The filing reports the options as directly beneficially owned following the transaction.
The options have an exercisable/expiration date entry of 09/24/2035 and the form states that 25% of the shares subject to the option vest annually on each anniversary of the grant date. The form is signed by an attorney-in-fact, Aimee Weast, under power of attorney dated 06/12/2025, with signature dated 09/26/2025.
Clayton M. Magouyrk, listed as Chief Executive Officer, reported a Section 16 Form 4 for Oracle Corporation (ORCL) reflecting a grant of stock options. The filing shows a derivative security described as a Stock Option with an exercise price of $308.46, dated 09/24/2025, for 2,593,530 option shares. The filing notes 25% of the shares subject to the option vest annually on each anniversary of the grant date. The reported options are held directly. The Form 4 was signed under power of attorney on 09/26/2025.
Oracle's definitive proxy discloses governance, succession and executive compensation actions for fiscal 2025. The company completed a planned CEO succession in September 2025: Safra Catz retired as CEO and PFO and became Executive Vice Chair, and Mr. Magouyrk and Mr. Sicilia were appointed as co-CEOs. Douglas Kehring was appointed Executive Vice President, Principal Financial Officer. The proxy calls for election of 13 directors, an advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as auditor for fiscal 2026.
The Compensation Committee elected not to pay annual cash bonuses for fiscal 2025 to preserve cash for strategic AI and growth priorities, and reduced performance-based bonuses to $0 (with one forfeiture noted). Long-term incentive outcomes included partial vesting of eight-year performance-based stock options. Key reported metrics include GAAP operating margin of 31% and GAAP earnings per share of $4.34. The proxy was first made available to stockholders on or about September 26, 2025.
Oracle Corporation reported documentation and terms for a proposed debt offering. The company references an existing S-3 registration statement filed March 15, 2024, and a preliminary and final prospectus supplement both dated September 24, 2025, indicating a securities offering process is underway.
Forms are provided for six note series: 4.450% due 2030, 4.800% due 2032, 5.200% due 2035, 5.875% due 2045, 5.950% due 2055, and 6.100% due 2065. An Officers' Certificate dated September 26, 2025 sets forth the notes' terms, and legal opinion and consent from Freshfields US LLP are included, along with an interactive cover page Inline XBRL file. The filing is administrative documentation of the planned note issuance rather than operating results.
ORCL Form 144 filing shows a proposed sale of 2,222 common shares through Fidelity Brokerage Services on 09/26/2025 with an aggregate market value of $641,958.24. The shares were acquired on 05/31/2022 by restricted stock vesting and were received as compensation. The filing also discloses that Naomi Seligman sold 3,303 common shares on 07/16/2025 for $770,656.29. The issuer's outstanding shares are listed as 2,841,714,000, indicating these transactions are small relative to total shares outstanding.
Michael D. Sicilia, listed as President, Industries, filed a Form 4 reporting multiple transactions in Oracle Corp (ORCL) securities between 09/19/2025 and 09/23/2025. Restricted stock units vested on 09/19/2025 (35,801 RSUs) and 09/20/2025 (73,411 RSUs), each RSU representing one share, and were reported as acquisitions under Code M. Shares were withheld to satisfy tax withholding on the 09/19 vesting. Separately, sales and dispositions occurred: 17,310 shares sold at $296.62 on 09/19/2025, 35,495 shares sold at $308.66 on 09/22/2025, and 33,845 shares sold at $321.16 on 09/23/2025 under a Rule 10b5-1 plan adopted 12/18/2024. Following the reported activity, the filing shows 132,656.279 shares beneficially owned directly and 2,655 shares indirectly by spouse.
Jeffrey Henley, Vice Chairman and a director of Oracle Corporation (ORCL), reported multiple insider transactions tied to vesting of restricted stock units and tax-withholding dispositions in September 2025. On 09/19/2025 and 09/20/2025 Henley had restricted stock units vest (codes M) resulting in acquisitions of 13,425 and 33,035 shares, settled at $0 as units converted into common stock. On 09/19/2025 and 09/22/2025 shares were withheld to satisfy tax liabilities (code F(1)), resulting in dispositions of 5,891 shares at $296.62 and 14,464 shares at $308.66. Following these reported transactions Henley’s beneficial ownership positions are shown as 1,016,303 and 1,001,839 shares (reported as indirect holdings by trusts), with additional holdings reported as 145,114 shares by a GRAT and 362,029 shares by the Henley Community Property Trust. The filings were signed by Aimee Weast as attorney-in-fact on 09/23/2025.
Maria Smith, EVP and Chief Accounting Officer of Oracle Corp (ORCL), reported several insider transactions tied to restricted stock units vesting. On 09/19/2025 she received 11,934 shares and on 09/20/2025 she received 5,506 shares as vesting restricted stock units. To satisfy tax obligations, 6,218 shares were withheld on 09/19/2025 at a per-share price of $296.62 and 2,869 shares were withheld on 09/22/2025 at $308.66. After these transactions, the form reports 57,083 shares beneficially owned.
The filing was signed on behalf of Ms. Smith by an attorney-in-fact, Aimee Weast, with a POA on file dated 01/04/2023.
Clayton M. Magouyrk, listed as President, OCI, reported multiple transactions in Oracle Corporation (ORCL) securities tied to restricted stock unit vesting in September 2025. On 09/19/2025 and 09/20/2025 a total of 129,861 restricted stock units vested and were converted into common stock at no cash price, increasing his beneficial ownership. To pay withholding taxes, on 09/19/2025 16,436 shares were surrendered at $296.62 each and on 09/22/2025 34,665 shares were surrendered at $308.66 each.
After the sequence of vesting and share-withholdings, Magouyrk beneficially owned 194,030 shares of Oracle common stock. The Form 4 was executed by an attorney-in-fact, Aimee Weast, under a power of attorney filed 06/12/2025, and signed on 09/23/2025.
FAQ
What is the current stock price of Oracle (ORCL)?
What is the market cap of Oracle (ORCL)?
